ID   CALD1_RAT               Reviewed;         531 AA.
AC   Q62736;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   27-MAR-2024, entry version 136.
DE   RecName: Full=Non-muscle caldesmon;
DE            Short=CDM;
DE   AltName: Full=L-caldesmon;
GN   Name=Cald1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS, AND PHOSPHORYLATION AT SER-249;
RP   SER-462; THR-468; SER-491; SER-497 AND SER-527.
RC   TISSUE=Liver;
RX   PubMed=7876150; DOI=10.1074/jbc.270.8.4023;
RA   Yamashiro S., Yamakita Y., Yoshida K.-S., Takiguchi K., Matsumura F.;
RT   "Characterization of the COOH terminus of non-muscle caldesmon mutants
RT   lacking mitosis-specific phosphorylation sites.";
RL   J. Biol. Chem. 270:4023-4030(1995).
RN   [2]
RP   PHOSPHORYLATION BY CDK1.
RX   PubMed=1986309; DOI=10.1038/349169a0;
RA   Yamashiro S., Yamakita Y., Hosoya H., Matsumura F.;
RT   "Phosphorylation of non-muscle caldesmon by p34cdc2 kinase during
RT   mitosis.";
RL   Nature 349:169-172(1991).
RN   [3]
RP   FUNCTION IN SCHWANN CELL MIGRATION, AND PHOSPHORYLATION BY CDK1.
RX   PubMed=17200138; DOI=10.1242/jcs.03322;
RA   Han I.S., Seo T.B., Kim K.-H., Yoon J.-H., Yoon S.-J., Namgung U.;
RT   "Cdc2-mediated Schwann cell migration during peripheral nerve
RT   regeneration.";
RL   J. Cell Sci. 120:246-255(2007).
CC   -!- FUNCTION: Actin- and myosin-binding protein implicated in the
CC       regulation of actomyosin interactions in smooth muscle and nonmuscle
CC       cells (could act as a bridge between myosin and actin filaments).
CC       Stimulates actin binding of tropomyosin which increases the
CC       stabilization of actin filament structure. In muscle tissues, inhibits
CC       the actomyosin ATPase by binding to F-actin. This inhibition is
CC       attenuated by calcium-calmodulin and is potentiated by tropomyosin.
CC       Interacts with actin, myosin, two molecules of tropomyosin and with
CC       calmodulin. Also plays an essential role during cellular mitosis and
CC       receptor capping. Involved in Schwann cell migration during peripheral
CC       nerve regeneration. {ECO:0000269|PubMed:17200138}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P13505}. Cytoplasm, myofibril
CC       {ECO:0000250|UniProtKB:P13505}. Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000250|UniProtKB:P13505}. Note=On thin filaments in smooth muscle
CC       and on stress fibers in fibroblasts (nonmuscle).
CC       {ECO:0000250|UniProtKB:P13505}.
CC   -!- TISSUE SPECIFICITY: High-molecular-weight caldesmon (h-caldesmon) is
CC       predominantly expressed in smooth muscles, whereas low-molecular-weight
CC       caldesmon (l-caldesmon) is widely distributed in non-muscle tissues and
CC       cells. Not expressed in skeletal muscle or heart.
CC   -!- DOMAIN: The N-terminal part seems to be a myosin/calmodulin-binding
CC       domain, and the C-terminal a tropomyosin/actin/calmodulin-binding
CC       domain. These two domains are separated by a central helical region in
CC       the smooth-muscle form.
CC   -!- PTM: In non-muscle cells, phosphorylation by CDK1 during mitosis causes
CC       caldesmon to dissociate from microfilaments. Phosphorylation reduces
CC       caldesmon binding to actin, myosin, and calmodulin as well as its
CC       inhibition of actomyosin ATPase activity. Phosphorylation also occurs
CC       in both quiescent and dividing smooth muscle cells with similar effects
CC       on the interaction with actin and calmodulin and on microfilaments
CC       reorganization. CDK1-mediated phosphorylation promotes Schwann cell
CC       migration during peripheral nerve regeneration.
CC       {ECO:0000269|PubMed:17200138, ECO:0000269|PubMed:1986309,
CC       ECO:0000269|PubMed:7876150}.
CC   -!- SIMILARITY: Belongs to the caldesmon family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U18419; AAA68521.1; -; mRNA.
DR   PIR; A55887; A55887.
DR   RefSeq; NP_037278.1; NM_013146.2.
DR   AlphaFoldDB; Q62736; -.
DR   SMR; Q62736; -.
DR   BioGRID; 247716; 2.
DR   STRING; 10116.ENSRNOP00000068857; -.
DR   iPTMnet; Q62736; -.
DR   PhosphoSitePlus; Q62736; -.
DR   jPOST; Q62736; -.
DR   PaxDb; 10116-ENSRNOP00000043767; -.
DR   GeneID; 25687; -.
DR   KEGG; rno:25687; -.
DR   UCSC; RGD:2256; rat.
DR   AGR; RGD:2256; -.
DR   CTD; 800; -.
DR   RGD; 2256; Cald1.
DR   eggNOG; ENOG502QSYB; Eukaryota.
DR   InParanoid; Q62736; -.
DR   OrthoDB; 4273102at2759; -.
DR   PhylomeDB; Q62736; -.
DR   Reactome; R-RNO-445355; Smooth Muscle Contraction.
DR   PRO; PR:Q62736; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030478; C:actin cap; ISO:RGD.
DR   GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0030016; C:myofibril; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0001725; C:stress fiber; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0017022; F:myosin binding; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:RGD.
DR   GO; GO:0001525; P:angiogenesis; IBA:GO_Central.
DR   GO; GO:0007565; P:female pregnancy; TAS:RGD.
DR   GO; GO:0006936; P:muscle contraction; IEA:InterPro.
DR   InterPro; IPR006017; Caldesmon.
DR   InterPro; IPR006018; Caldesmon_LSP.
DR   PANTHER; PTHR18949; CALDESMON; 1.
DR   PANTHER; PTHR18949:SF0; CALDESMON; 1.
DR   Pfam; PF02029; Caldesmon; 1.
DR   PRINTS; PR01076; CALDESMON.
PE   1: Evidence at protein level;
KW   Actin-binding; Calmodulin-binding; Cytoplasm; Cytoskeleton;
KW   Isopeptide bond; Muscle protein; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..531
FT                   /note="Non-muscle caldesmon"
FT                   /id="PRO_0000089290"
FT   REGION          20..200
FT                   /note="Myosin and calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          21..379
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          303..360
FT                   /note="Tropomyosin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          392..424
FT                   /note="Strong actin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          402..412
FT                   /note="Tropomyosin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          454..460
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          458..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          506..531
FT                   /note="Weak actin-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        22..56
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        57..74
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        86..117
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..138
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..157
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        171..229
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..253
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..379
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05682"
FT   MOD_RES         249
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05682"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05682"
FT   MOD_RES         462
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MOD_RES         468
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MOD_RES         491
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MOD_RES         497
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MOD_RES         527
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   CROSSLNK        384
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q05682"
FT   MUTAGEN         249
FT                   /note="S->A: Decreases strongly phosphorylation-dependent
FT                   actin binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MUTAGEN         462
FT                   /note="S->A: Decreases phosphorylation-dependent actin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MUTAGEN         468
FT                   /note="T->A: Decreases phosphorylation-dependent actin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MUTAGEN         491
FT                   /note="S->A: Decreases phosphorylation-dependent actin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MUTAGEN         497
FT                   /note="S->A: Decreases phosphorylation-dependent actin
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
FT   MUTAGEN         527
FT                   /note="S->A: Does not decrease phosphorylation-dependent
FT                   actin binding."
FT                   /evidence="ECO:0000269|PubMed:7876150"
SQ   SEQUENCE   531 AA;  60584 MW;  CBBEC50271A23829 CRC64;
     MLSRSGSQGR RCLATLSQIA YQRNDDDEEE AARERRRRAR QERLRQKQEE ESLGQVTDQV
     EAHVQNSAPD EESKPATANA QVEGDEEAAL LERLARREER RQKRLQEALE RQKEFDPTIT
     DGSLSVPSRR MQNNSAENET AEGEEKGESR SGRYEMEETE VVITSYQKNS YQDAEDKKKE
     EKEEEEEEEK LKGGNLGENQ IKDEKIKKDK EPKEEVKNFL DRKKGFTEVK AQNGEFMTHK
     LKQTENAFSP SRSGGRASGD KEAEGAPQVE AGKRLEELRR RRGETESEEF EKLKQKQQEA
     ALELEELKKK REERRKVLEE EEQRRKQEEA DRKAREEEEK RRLKEEIERR RAEAAEKRQK
     MPEDGLSEDK KPFKCFTPKG SSLKIEERAE FLNKSVQKSG VKSTHQAAVV SKIDSRLEQY
     TNAIEGTKAS KPMKPAASDL PVPAEGVRNI KSMWEKGSVF SSPSASGTPN KETAGLKVGV
     SSRINEWLTK SPDGNKSPAP KPSDLRPGDV SGKRNLWEKQ SVDKVTSPTK V
//
